Project Grant CLSS00000086239

This federal Project Grant award of $120,348.00, provided by the U.S. Department of Agriculture (USDA) Rural Utilities Service's Distance Learning and Telemedicine (DLT) Loans and Grants program (CFDA 10.855), supports the Southern Tier Health Care System, Inc. (STHCS) in delivering substance use disorder-related educational services to rural communities in New York. The funding will enable STHCS, a non-profit organization, to utilize telecommunications technologies to remotely provide substance...

The University of Nevada, Reno received a $402,205 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), effective May 1, 2026 through April 30, 2028. The project delivers applied health services research examining opioid use disorder (OUD) treatment access and outcomes for dual Medicare and Medicaid enrollees. Using Medicare Advantage claims data and enrollment records from 2021-2024, the research team will conduct a...

Summary The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded the California Department of Health Care Services a $195.4 million block grant under the Block Grants for Prevention and Treatment of Substance Abuse program (CFDA 93.959) effective October 1, 2025, through September 30, 2027. This funding supports the development and implementation of comprehensive substance use prevention, treatment, and recovery services throughout...

The Fulton County Department of Behavioral Health and Disabilities (DBHDD), in partnership with the Atlanta Policing Alternatives & Diversion Initiative (PAD), has been awarded a $1,599,999 Project Grant under the U.S. Department of Justice's Comprehensive Opioid, Stimulant, and other Substance Use Program (COSSUP). The grant will fund the Fulton County Diversion and Deflection Recovery Program (FDR) to address substance use disorders, promote public safety, and increase access to...

Federal Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop an advanced medication adherence and monitoring system for decentralized clinical trials (DCTs) in substance use disorder (SUD) treatment. The award, effective from September 1, 2025, through August 31, 2026, supports the adaptation of Addinex's existing medication management platform to...

Summary The District of Columbia Government, through its Department of Behavioral Health, received a $5.65 million Block Grant for Prevention and Treatment of Substance Abuse (CFDA 93.959) from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment, effective October 1, 2025, through September 30, 2027. This funding supports the development and implementation of comprehensive substance use prevention, treatment, and recovery services across...

Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital a $395,280 Project Grant effective July 1, 2025 through June 30, 2030 under the Drug Use and Addiction Research Programs (CFDA 93.279). Dr. Collins will develop and conduct a pilot randomized controlled trial for AMP-C, a digital therapeutic (DTX) designed to address reward dysfunction in individuals with co-occurring Cannabis Use Disorder (CUD) and Major Depressive Disorder...

Federal Grant Award Summary Boston Medical Center Corporation received a $3.2M Project Grant award from the Health Resources and Services Administration (HRSA), Bureau of Health Professionals, under the Addiction Medicine Fellowship Program and Integrated Substance Use Disorder Training Program (CFDA 93.841), effective July 1, 2025 through June 30, 2030. The grant supports the development and expansion of an interdisciplinary addiction medicine and addiction psychiatry fellowship program...

The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $4.7 million Block Grant to the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD) for the period of September 1, 2021 through September 30, 2025 under the Block Grants for Prevention and Treatment of Substance Abuse (CFDA 93.959) program. The funding supports several substance abuse prevention and treatment services delivered by DBHDD and various...

The Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment awarded the Tennessee Department of Mental Health & Substance Abuse Services (TDMHSAS) a Block Grant for Prevention and Treatment of Substance Abuse (CFDA 93.959) totaling $26.9 million, effective October 1, 2025, through September 30, 2027. This block grant funding supports the development and implementation of comprehensive substance use prevention, treatment, and rehabilitation...